Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study

Go back to Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
(NASDAQ: THTX) Delayed: 3.39 --0 (-0%)
Previous Close $3.39    52 Week High $ 
Open $3.39    52 Week Low $ 
Day High $3.39    P/E N/A 
Day Low $3.39    EPS $ 
Volume 254       

(NASDAQ: THTX) Delayed: 3.39 --0 (-0%)
Previous Close $3.39    52 Week High $ 
Open $3.39    52 Week Low $ 
Day High $3.39    P/E N/A 
Day Low $3.39    EPS $ 
Volume 254